Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04094818 · ClinicalTrials.gov registry record
TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
A clinical trial, sponsored by Inflammatix.
- Completed
- Registry status
- 1,441
- Enrollment target
NCT04094818: Completed study, sponsored by Inflammatix.
NCT04094818 is a clinical trial that has completed, run by Inflammatix. The registered enrollment target is 1,441 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04094818 has completed, sponsored by Inflammatix.
- COMPLETED
- Registry status
- 1,441 participants
- Enrollment target
Study Summary
This study will analyze gene expression and other laboratory data from biological samples collected from participants with suspected respiratory, urinary, intra-abdominal, and/or skin \& soft tissue infections; or suspected sepsis of any cause.
Primary Outcome
Concordance of HostDx Sepsis bacterial readout with clinical adjudication
Interventions
- DIAGNOSTIC_TEST TriVerity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,441 participants |
| Start Date | 2020-02-28 |
| Est. Completion | 2024-09-30 |
What the finished NCT04094818 record still lists
NCT04094818 is an observational study that tracks outcomes without assigning an intervention. Its 1,441 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which TriVerity is the first listed.
NCT04094818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04094818 about?
NCT04094818 is a clinical study titled "TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis". This study will analyze gene expression and other laboratory data from biological samples collected from participants with suspected respiratory, urinary, intra-abdominal, and/or skin \& soft tissue infections; or suspected sepsis of any cause.
What is the current status of trial NCT04094818?
This trial is currently completed. The enrollment target is 1,441 participants. The study started on 2020-02-28. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT04094818?
The interventions under investigation include: TriVerity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04094818?
This trial is sponsored by Inflammatix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI